Skip to main content
Erschienen in: Clinical Autonomic Research 3/2006

01.06.2006 | RESEARCH ARTICLE

Gene expression, autonomic function and chronic hypoxia:lessons from the Andes

verfasst von: Otto Appenzeller, MD, PhD, Tamara Minko, PhD, Clifford Qualls, PhD, Vitaly Pozharov, PhD, Jorge Gamboa, MD, Alfredo Gamboa, MD, Yang Wang, BSc

Erschienen in: Clinical Autonomic Research | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Autonomic function is altered by altitude in sojourners and natives. We hypothesized that these physiologic responses are modulated by changes in gene expression. We compared gene product levels in 20 natives of Cerro de Pasco (CP), (4338 m), 10 of which had chronic mountain sickness (CMS) established by a CMS-scoring system, with gene products in the same men after 1 h at sea level. We further compared the results with those obtained from 10 US men residing at 1500 m. We measured gene products in white cells by reverse transcription polymerase chain reaction (RT-PCR). We focused on genes important in vascular autonomic physiology, and/or activated by hypoxia; hypoxia inducible factor 1-α (HIF 1-α), 2 splicing variants of vascular endothelial growth factor (VEGF); VEGF-121, VEGF-165, and phosphoglycerate kinase 1 (PGK 1).
Normal CP natives showed high expression of all genes in CP, compared to US controls. Within 1 h of arrival at sea level, they had comparable levels to US residents. In CMS, the gene products were higher in CP. Although gene products decreased in Lima in this group, they never reached US values. VEGF 121 and 165 were correlated (P<0.001). VEGF 165 was higher in CMS in CP (P=0.006), and was positively correlated with CMS-score (R=0.86, P<0.001), and negatively correlated with arterial saturation (R=−0.79, P<0.001).
Our findings underscore the changes in gene expression levels in intact humans in response to environmental stress. These changes may support the physiologic alterations induced by the ambient hypoxia at altitude and impact organism survival. They also suggest therapeutic strategies for autonomic and neurodegenerative diseases at sea level.
Literatur
1.
Zurück zum Zitat Appenzeller O, Minko T, Pozharov V, Bonfichi M, Malcovati L, Gamboa J, Bernardi L (2003) Gene expression in the Andes; relevance to neurology at sea level. J Neurol Sci 207:37–41PubMedCrossRef Appenzeller O, Minko T, Pozharov V, Bonfichi M, Malcovati L, Gamboa J, Bernardi L (2003) Gene expression in the Andes; relevance to neurology at sea level. J Neurol Sci 207:37–41PubMedCrossRef
2.
Zurück zum Zitat Claydon VE, Norcliffe LJ, Moore JP, Rivera-Ch M, Leon-Velarde F, Appenzeller O, Hainsworth R (2004) Orthostatic tolerance and blood volumes in Andean high altitude dwellers. Exp Physiol 89:565–571PubMedCrossRef Claydon VE, Norcliffe LJ, Moore JP, Rivera-Ch M, Leon-Velarde F, Appenzeller O, Hainsworth R (2004) Orthostatic tolerance and blood volumes in Andean high altitude dwellers. Exp Physiol 89:565–571PubMedCrossRef
3.
Zurück zum Zitat Cornelussen RNM, Vanagt WYR, Prinzen FW, Snoeckx LHEH (2003) Proteins involved in salvage of the myocardium. In: Roach RC, Wagner PD, Hackett PH (eds) Hypoxia: through the lifecycle. Kluwer Academic/Plenum Publishers, New York, pp 277–291 Cornelussen RNM, Vanagt WYR, Prinzen FW, Snoeckx LHEH (2003) Proteins involved in salvage of the myocardium. In: Roach RC, Wagner PD, Hackett PH (eds) Hypoxia: through the lifecycle. Kluwer Academic/Plenum Publishers, New York, pp 277–291
4.
Zurück zum Zitat Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 305:1292–1295 PubMedCrossRef Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 305:1292–1295 PubMedCrossRef
5.
Zurück zum Zitat Drewes LR (2001) Molecular architecture of the brain microvasculature: perspective on blood–brain transport. J Mol Neurosci 16:7–12 Drewes LR (2001) Molecular architecture of the brain microvasculature: perspective on blood–brain transport. J Mol Neurosci 16:7–12
6.
Zurück zum Zitat Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247PubMedCrossRef Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247PubMedCrossRef
8.
Zurück zum Zitat Goldman SA, Nedergaard M (2002) Erythropoietin strikes a new cord. Nat Med 8:495–505CrossRef Goldman SA, Nedergaard M (2002) Erythropoietin strikes a new cord. Nat Med 8:495–505CrossRef
9.
Zurück zum Zitat Höpfl G, Ogunshola O, Gassmann M (2003) Hypoxia and high altitude. The molecular response. In: Roach RC, Wagner PD, Hackett PH (eds) Hypoxia: through the lifecycle. Kluwer Academic/Plenum Publishers, New York, pp 98–116 Höpfl G, Ogunshola O, Gassmann M (2003) Hypoxia and high altitude. The molecular response. In: Roach RC, Wagner PD, Hackett PH (eds) Hypoxia: through the lifecycle. Kluwer Academic/Plenum Publishers, New York, pp 98–116
10.
Zurück zum Zitat León-Velarde F, Ramos MA, Hernandes JA, De Idiaquez D, Munoz LS, Gaffo A, Cordova S, Durand D, Monge C (1997) The role of menopause in the development of chronic mountain sickness. Am J Physiol 272:R90–R94PubMed León-Velarde F, Ramos MA, Hernandes JA, De Idiaquez D, Munoz LS, Gaffo A, Cordova S, Durand D, Monge C (1997) The role of menopause in the development of chronic mountain sickness. Am J Physiol 272:R90–R94PubMed
11.
Zurück zum Zitat León-Velarde F, McCullough RG, McCullough RE, Reeves JT (2003) Proposal for scoring severity in chronic mountain sickness (CMS). In: Roach RC, Wagner PD, Hackett PH (eds) Hypoxia: Through the lifecycle. Kluwer Academic/Plenum Publishers, New York, pp 339–354 León-Velarde F, McCullough RG, McCullough RE, Reeves JT (2003) Proposal for scoring severity in chronic mountain sickness (CMS). In: Roach RC, Wagner PD, Hackett PH (eds) Hypoxia: Through the lifecycle. Kluwer Academic/Plenum Publishers, New York, pp 339–354
12.
Zurück zum Zitat Levine BD (2000) Mountain medicine and the autonomic nervous system. In: Appenzeller O (eds) Handbook of clinical neurology 75 (31): the autonomic nervous system. Part II Dysfunction. Elsevier, Amsterdam, pp 259–280 Levine BD (2000) Mountain medicine and the autonomic nervous system. In: Appenzeller O (eds) Handbook of clinical neurology 75 (31): the autonomic nervous system. Part II Dysfunction. Elsevier, Amsterdam, pp 259–280
13.
Zurück zum Zitat Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277:23111–23115PubMedCrossRef Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277:23111–23115PubMedCrossRef
14.
Zurück zum Zitat Monge MC (1925) Sobre un caso de enfermedad de Váquez. Presented at: Academia Nacional de Medicina Lima 1:1–7 Monge MC (1925) Sobre un caso de enfermedad de Váquez. Presented at: Academia Nacional de Medicina Lima 1:1–7
15.
Zurück zum Zitat Peñalosa D, Sime F, Ruiz L (1971) Cor Pulmonale in chronic mountain sickness: present concept of Monge’s disease. In: Portet R, Knight J (eds) High altitude physiology; cardiac and respiratory aspects. Churchill Livingston, Edinburgh, pp 41–60 Peñalosa D, Sime F, Ruiz L (1971) Cor Pulmonale in chronic mountain sickness: present concept of Monge’s disease. In: Portet R, Knight J (eds) High altitude physiology; cardiac and respiratory aspects. Churchill Livingston, Edinburgh, pp 41–60
16.
Zurück zum Zitat Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345–350PubMedCrossRef Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345–350PubMedCrossRef
17.
Zurück zum Zitat Sharp FR, Bernaudin M (2004) HIF 1 and oxygen sensing in the brain. Nat Rev Neuroscience 5:437–448CrossRef Sharp FR, Bernaudin M (2004) HIF 1 and oxygen sensing in the brain. Nat Rev Neuroscience 5:437–448CrossRef
18.
Zurück zum Zitat Sime F, Monge CC, Whittemburry J (1975) Age as a cause of chronic mountain sickness (Monge’s disease). Int J Biometeorol 19:93–98PubMedCrossRef Sime F, Monge CC, Whittemburry J (1975) Age as a cause of chronic mountain sickness (Monge’s disease). Int J Biometeorol 19:93–98PubMedCrossRef
19.
Zurück zum Zitat Storkbaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943–954CrossRef Storkbaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943–954CrossRef
20.
Zurück zum Zitat Tassorelli C, Nappi RE, Blandini F, Micieli G, Nappi G (1999) Stress and the autonomic nervous system. In: Appenzeller O (eds) Handbook of clinical neurology 74 (30): the autonomic nervous system. Part I normal functions. Elsevier, Amsterdam, pp 304–349 Tassorelli C, Nappi RE, Blandini F, Micieli G, Nappi G (1999) Stress and the autonomic nervous system. In: Appenzeller O (eds) Handbook of clinical neurology 74 (30): the autonomic nervous system. Part I normal functions. Elsevier, Amsterdam, pp 304–349
21.
Zurück zum Zitat Thomas PK, King RHM, Feng SF, Muddle JR, Workman JM, Gamboa J, Tapia R, Vargas M, Appenzeller O (2000) Neurological manifestations in chronic mountain sickness: the burning feet-burning hands syndrome. J Neurol Neurosurg Psychiatry 69:447–452PubMedCrossRef Thomas PK, King RHM, Feng SF, Muddle JR, Workman JM, Gamboa J, Tapia R, Vargas M, Appenzeller O (2000) Neurological manifestations in chronic mountain sickness: the burning feet-burning hands syndrome. J Neurol Neurosurg Psychiatry 69:447–452PubMedCrossRef
Metadaten
Titel
Gene expression, autonomic function and chronic hypoxia:lessons from the Andes
verfasst von
Otto Appenzeller, MD, PhD
Tamara Minko, PhD
Clifford Qualls, PhD
Vitaly Pozharov, PhD
Jorge Gamboa, MD
Alfredo Gamboa, MD
Yang Wang, BSc
Publikationsdatum
01.06.2006
Erschienen in
Clinical Autonomic Research / Ausgabe 3/2006
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-006-0338-3

Weitere Artikel der Ausgabe 3/2006

Clinical Autonomic Research 3/2006 Zur Ausgabe

IN THIS ISSUE

In This Issue

Neu in den Fachgebieten Neurologie und Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.